Submitted:
30 January 2024
Posted:
30 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
3.1. Nursing home demographics
3.2. Screening strategies for staff, residents, and visitors
3.3. Management of staff and residents who test positive and/or present symptoms compatible with COVID-19
3.4. Shortages of personal protective equipment
3.5. Existing infection containment policies
3.6. Frequency of social interactions
3.7. COVID-19 information dissemination
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A. Semi-Structured Interview
- During the first wave of COVID-19, between March 1, 2020, and June 1, 2020, did you implement local screening strategies (e.g., temperature measurement, RT-PCR testing)? If yes, please specify what was implemented,
- for staff?
- for residents?
- for visitors?
- 2.
- How did you manage employees with a positive test or close contact with a positive case?
- 3.
- How did you handle employees that presented symptoms consistent with COVID-19?
- 4.
- How did you manage residents with a COVID-19-positive test result?
- 5.
- Between March 1, 2020, and June 1, 2020, how did you manage residents that presented symptoms consistent with COVID-19? (e.g., isolation, hospitalization, protective equipment for caregivers)
- Did you experience a shortage of personal protective equipment (PPE) during the first wave, between March 1, 2020, and June 1, 2020? If yes, please provide details:
- What type of PPE was lacking (e.g., surgical masks, N95 masks, gowns, face shields, safety goggles, hand sanitizer, gloves)?
- How long did the shortage last?
- How did you manage this shortage?
- What PPE was eventually provided, and when?
- Did you have an epidemic protection plan for the nursing home before this outbreak? If yes, did this plan serve for the COVID-19 pandemic?
- Did you restrict access to certain common areas?
- Were in-person activities suspended? If yes, which ones were suspended, and which continued?
- Did you implement social distancing measures among residents?
- How did you ensure hand hygiene for staff in your facility (e.g., hand sanitizer dispensers in common areas, posters, training)?
- How did you ensure hand hygiene for residents in your facility (e.g., hand sanitizer dispensers in rooms, posters, informational sessions)?
- Did you have a mask-wearing protocol between March 1, 2020 and June 1, 2020? If yes, when and how was it implemented (e.g., for employees, residents, visitors)?
- Did you ban/restrict visits? If yes, when and how (e.g., restricted visiting hours, limited number of visitors, physical contact allowed)?
- Did you receive instructions from your nursing home association and/or the Department of Health or the cantonal physician regarding preventive measures against COVID-19? If yes, were you able to follow them?
- Did you take other measures to limit contact between residents and between caregiving staff and residents (e.g., assigning specific staff to specific residents, resident groups, or areas within the nursing home)?
- Did employees receive training on COVID-19 prevention measures? If yes, when, in what format, and was it mandatory or optional?
- Did physicians undergo training for COVID-19? If yes, when, in what format, and was it mandatory or optional?
- Did residents have the opportunity to participate in information sessions about COVID-19 (hygiene measures and social distancing)? If yes, when, in what format, and was it mandatory or optional?
- In your opinion, what were the strengths and weaknesses of your nursing home in managing the COVID-19 health crisis?
- Are you a part of a nursing home association or umbrella organization?
Appendix B. Demographic Survey
- How many people were present on-site in your facility between March 1, 2020, and June 1, 2020 (including temporary staff)?
- 2.
- What percentage of healthcare staff work part-time?
- 3.
- How many *caregivers worked in your nursing home between March 1, 2020, and June 1, 2020?
- 4.
- What is the age distribution of all employees?
- 5.
- What is the gender distribution of all employees?
- How many times per week did the physician associated with your facility and involved in institutional life visit the nursing home during the period from March 1, 2020 to June 1, 2020?
- What is the age distribution of residents?
- What is the gender distribution of residents?
- What was the number of beds and the occupancy rate per month between March 1, 2020, and June 1, 2020?
- Did you prohibit visits from family/relatives during the period from March 1, 2020, and June 1, 2020? If yes, between which dates?
- How many individual rooms are there in the nursing home? How many shared rooms are there in the nursing home?
References
- Jordan, R.E.; Adab, P.; Cheng, K.K. Covid-19: risk factors for severe disease and death. BMJ 2020, 26, m1198. [Google Scholar] [CrossRef] [PubMed]
- Wisniak, A.; Menon, L.K.; Dumont, R.; Pullen, N.; Regard, S.; Dubos, R.; et al. Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study. Viruses 2021, 14, 43. [Google Scholar] [CrossRef] [PubMed]
- Stringhini, S.; Zaballa, M.E.; Pullen, N.; de Mestral, C.; Perez-Saez, J.; Dumont, R.; et al. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021, 12, 3455. [Google Scholar] [CrossRef] [PubMed]
- Ayalon, L.; Zisberg, A.; Cohn-Schwartz, E.; Cohen-Mansfield, J.; Perel-Levin, S.; Bar-Asher Siegal, E. Long-term care settings in the times of COVID-19: challenges and future directions. Int Psychogeriatr. 2020, 32, 1239–43. [Google Scholar] [CrossRef] [PubMed]
- Adil, M.T.; Rahman, R.; Whitelaw, D.; Jain, V.; Al-Taan, O.; Rashid, F.; et al. SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J. 2021, 97, 110. [Google Scholar] [CrossRef] [PubMed]
- Flaxman, S.; Mishra, S.; Gandy, A.; Unwin, H.J.T.; Mellan, T.A.; Coupland, H.; et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 2020, 584, 257–61. [Google Scholar] [CrossRef] [PubMed]
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual Res Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef]
- Scanferla, G.; Héquet, D.; Graf, N.; Münzer, T.; Kessler, S.; Kohler, P.; et al. COVID-19 burden and influencing factors in Swiss long-term-care facilities: a cross-sectional analysis of a multicentre observational cohort. Swiss Med Wkly. 2023, 153, 40052. [Google Scholar] [CrossRef] [PubMed]
- McMichael, T.M.; Clark, S.; Pogosjans, S.; Kay, M.; Lewis, J.; Baer, A.; et al. COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020. MMWR Morb Mortal Wkly Rep. 2020, 69, 339–42. [Google Scholar] [CrossRef] [PubMed]
- Dykgraaf, S.H.; Matenge, S.; Desborough, J.; Sturgiss, E.; Dut, G.; Roberts, L.; et al. Protecting Nursing Homes and Long-Term Care Facilities From COVID-19: A Rapid Review of International Evidence. J Am Med Dir Assoc. 2021, 22, 1969–88. [Google Scholar] [CrossRef] [PubMed]
- Belmin, J.; Um-Din, N.; Donadio, C.; Magri, M.; Nghiem, Q.D.; Oquendo, B.; et al. Coronavirus Disease 2019 Outcomes in French Nursing Homes That Implemented Staff Confinement With Residents. JAMA Netw Open. 2020, 3, e2017533. [Google Scholar] [CrossRef] [PubMed]
- Hugelius, K.; Harada, N.; Marutani, M. Consequences of visiting restrictions during the COVID-19 pandemic: An integrative review. Int J Nurs Stud. 2021, 121, 104000. [Google Scholar] [CrossRef] [PubMed]
- Verbeek, H.; Gerritsen, D.L.; Backhaus, R.; De Boer, B.S.; Koopmans, R.T.C.M.; Hamers, J.P.H. Allowing Visitors Back in the Nursing Home During the COVID-19 Crisis: A Dutch National Study Into First Experiences and Impact on Well-Being. J Am Med Dir Assoc. 2020, 21, 900–4. [Google Scholar] [CrossRef] [PubMed]



| COVID-19 measures | IRR* (95% CI) | p-value |
|---|---|---|
| Minimally restrictive | Ref | |
| Moderately restrictive | 3.55 (0.75-41.42) | 0.212 |
| Maximally restrictive | 3.90 (0.82-45.54) | 0.184 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).